NCT07513181

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06Est. Completion: 2028-12-14

Enrollment target: 120 participants

Locations

Contact

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis

Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …

Bethesda, United StatesEst. completion Jun 1, 2036

Inflammatory Bowel Disease

Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…

Chicago, United StatesEst. completion Sep 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.